Cancer Investigation
Volume 35, 2017 - Issue 8
Open access
3,676
Views
49
CrossRef citations to date
0
Altmetric
Cancer Investigation
Realizing the Potential of Vascular Targeted Therapy: The Rationale for Combining Vascular Disrupting Agents and Anti-Angiogenic Agents to Treat Cancer
D. W. SiemannDepartment of Radiation Oncology, University of Florida, Gainesville, FL, USACorrespondence[email protected]
, D. J. ChaplinMateon Therapeutics, South San Francisco, CA, USA
& M. R. HorsmanDepartment of Experimental Clinical Oncology, Aarhus University, Denmark
Pages 519-534
|
Received 16 May 2017, Accepted 03 Aug 2017, Published online: 05 Sep 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.